"VIBRATIONS" - A Study In Smokers Who Are Willing And Motivated To Stop Smoking With The Aid Of Varenicline Which Will Be Prescribed According To Usual Clinical Practice In Germany

Pfizer

Status: Completed

Conditions: Smoking Cessation

Treatments: Drug: Varenicline

Study type: Observational

Funder types: Industry

Identifiers

NCT01104636

A3051141

Details and patient eligibility

About

The aim of this study is to determine the success rates for stopping smoking with varenicline in Germany. The main measure of success will be continuous abstinence from smoking (not a single puff) in the last week of the standard 12 week treatment period. Additional information will be gathered regarding prescribing practices in Germany, smoking history, reasons why smokers quit smoking and re-start smoking, smoking related illnesses and the tolerability of varenicline.

Full description

Sampling Method Details: Non-interventional study: subjects to be selected according to the usual clinical practice of their physician.

Enrollment: 1,177 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Legal adult age
• Regular smoker, with main tobacco product smoked being cigarettes, and willing and motivated to stop smoking
• Evidence of a personally signed and dated Informed Consent document.

Exclusion criteria

• Any subjects considered unsuitable according to the Summary of product characteristics (SmPC)

Trial design

1,177 participants in 1 patient group

Single group prospective treatment cohort (varenicline)

Treatment:

Drug: Varenicline